Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway

MicroRNA-145-3p suppresses proliferation and promotes apotosis and autophagy of osteosarcoma cell by targeting HDAC4

(2018) Guangzhi Wu et al.   Artificial Cells Nanomedicine and Biotechnology

Transforming growth factor β and its role in heart disease

(2017) Guangwang Liu et al.   Experimental and Therapeutic Medicine

Application of nanocarrier-based drug delivery system in treatment of oral cancer

(2017) Abhishek K. Sah et al.   Artificial Cells Nanomedicine and Biotechnology

Mechanisms of Chinese Medicine Xinmailong’s protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes

(2017) Jianyong Qi et al.   Scientific Reports

Delivery of tanshinone IIA and α-mangostin from gold/PEI/cyclodextrin nanoparticle platform designed for prostate cancer chemotherapy

(2016) Shihong Qiu et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB

(2016) Jin-Xiu Yang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Tanshinone IIA inhibits myocardial remodeling induced by pressure overload via suppressing oxidative stress and inflammation: Possible role of silent information regulator 1

(2016) Jun Feng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Tanshinone IIA inhibits angiotensin II induced extracellular matrix remodeling in human cardiac fibroblasts — Implications for treatment of pathologic cardiac remodeling

(2016) Shuai Mao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Biosynthesis of silver nanoparticles by Novosphingobium sp. THG-C3 and their antimicrobial potential

(2016) Juan Du et al.   Artificial Cells Nanomedicine and Biotechnology

Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reaction

(2015) Huilin Hu et al.   PHARMACEUTICAL BIOLOGY

Phytoestrogen, tanshinone IIA diminishes collagen deposition and stimulates new elastogenesis in cultures of human cardiac fibroblasts

(2014) Shuai Mao et al.   EXPERIMENTAL CELL RESEARCH

Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling

(2013) Xiu Q. Zhang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles

(2013) Jiang et al.   International Journal of Nanomedicine

Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan

(2013) Qi-yuan Liu et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Celastrol inhibits interleukin-17A-stimulated rheumatoid fibroblast-like synoviocyte migration and invasion through suppression of NF-κB-mediated matrix metalloproteinase-9 expression

(2012) Guo-qing Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Cardiovascular actions and therapeutic potential of tanshinone IIA

(2011) Si Gao et al.   ATHEROSCLEROSIS

Multiple Facets of NF-κB in the Heart

(2011) Joseph W. Gordon et al.   CIRCULATION RESEARCH

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy

(2010) Justin A. Ezekowitz et al.   AMERICAN HEART JOURNAL

Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension

(2009) Y.-M. Kang et al.   CARDIOVASCULAR RESEARCH

Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats

(2009) Y. Zhang et al.   DIABETES OBESITY & METABOLISM

The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction

(2009) Marcin Dobaczewski et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY